-
1
-
-
78650978283
-
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro
-
Gubareva LV, Trujillo AA, Okomo-Adhiambo M et al. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antivir Ther 2010; 15:1151-1159.
-
(2010)
Antivir Ther
, vol.15
, pp. 1151-1159
-
-
Gubareva, L.V.1
Trujillo, A.A.2
Okomo-Adhiambo, M.3
-
3
-
-
84455192539
-
Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection
-
Sugaya N, Kohno S, Ishibashi T et al. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection. Antimicrob Agents Chemother 2012; 56:369-377.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 369-377
-
-
Sugaya, N.1
Kohno, S.2
Ishibashi, T.3
-
4
-
-
62349105166
-
Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08
-
Hauge SH, Dudman S, Borgen K et al. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 2009; 15:155-162.
-
(2009)
Emerg Infect Dis
, vol.15
, pp. 155-162
-
-
Hauge, S.H.1
Dudman, S.2
Borgen, K.3
-
5
-
-
40549111528
-
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe
-
pii:.
-
Lackenby A, Hungnes O, Dudman SG et al. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill 2008; 13:pii:8026.
-
(2008)
Euro Surveill
, vol.13
, pp. 8026
-
-
Lackenby, A.1
Hungnes, O.2
Dudman, S.G.3
-
6
-
-
64749089192
-
Update: influenza activity-United States, September 28, 2008-April 4and composition of the 2009-10 influenza vaccine
-
CDC
-
CDC. Update: influenza activity-United States, September 28, 2008-April 4and composition of the 2009-10 influenza vaccine. Morb Mortal Wkly Rep 2009; 58:369-374.
-
(2009)
Morb Mortal Wkly Rep
, vol.58
, pp. 369-374
-
-
-
7
-
-
72049131299
-
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season
-
Baranovich T, Saito R, Suzuki Y et al. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. J Clin Virol 2010; 47:23-28.
-
(2010)
J Clin Virol
, vol.47
, pp. 23-28
-
-
Baranovich, T.1
Saito, R.2
Suzuki, Y.3
-
8
-
-
65349131787
-
Update: infections with a swine-origin influenza A (H1N1) virus-United States and other countries, April 28, 2009
-
CDC
-
CDC. Update: infections with a swine-origin influenza A (H1N1) virus-United States and other countries, April 28, 2009. Morb Mortal Wkly Rep 2009; 58:431-433.
-
(2009)
Morb Mortal Wkly Rep
, vol.58
, pp. 431-433
-
-
-
9
-
-
79551650598
-
Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States
-
Graitcer SB, Gubareva L, Kamimoto L et al. Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis 2011; 17:255-257.
-
(2011)
Emerg Infect Dis
, vol.17
, pp. 255-257
-
-
Graitcer, S.B.1
Gubareva, L.2
Kamimoto, L.3
-
10
-
-
84856325057
-
Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11
-
Storms AD, Gubareva LV, Su S et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis 2012; 18:308-311.
-
(2012)
Emerg Infect Dis
, vol.18
, pp. 308-311
-
-
Storms, A.D.1
Gubareva, L.V.2
Su, S.3
-
11
-
-
79951568635
-
Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11
-
Lackenby A, Moran GJ, Pebody R et al. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill 2011; 16:19784.
-
(2011)
Euro Surveill
, vol.16
, pp. 19784
-
-
Lackenby, A.1
Moran, G.J.2
Pebody, R.3
-
12
-
-
80052842317
-
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010
-
Meijer A, Jonges M, Abbink F et al. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antiviral Res 2011; 92:1-89.
-
(2011)
Antiviral Res
, vol.92
, pp. 1-89
-
-
Meijer, A.1
Jonges, M.2
Abbink, F.3
-
13
-
-
79952319815
-
Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010
-
Ujike M, Ejima M, Anraku A et al. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerg Infect Dis 2011; 17:470-479.
-
(2011)
Emerg Infect Dis
, vol.17
, pp. 470-479
-
-
Ujike, M.1
Ejima, M.2
Anraku, A.3
-
14
-
-
84855400938
-
Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza
-
Hurt AC, Hardie K, Wilson NJ et al. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med 2011; 365:2541-2542.
-
(2011)
N Engl J Med
, vol.365
, pp. 2541-2542
-
-
Hurt, A.C.1
Hardie, K.2
Wilson, N.J.3
-
15
-
-
84862902952
-
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia
-
Hurt AC, Hardie K, Wilson NJ et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis 2012; 206:148-157.
-
(2012)
J Infect Dis
, vol.206
, pp. 148-157
-
-
Hurt, A.C.1
Hardie, K.2
Wilson, N.J.3
-
16
-
-
84864557850
-
The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors
-
Hurt AC, Okomo-Adhiambo M, Gubareva LV. The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors. Methods Mol Biol 2012; 865:115-125.
-
(2012)
Methods Mol Biol
, vol.865
, pp. 115-125
-
-
Hurt, A.C.1
Okomo-Adhiambo, M.2
Gubareva, L.V.3
-
17
-
-
84864536567
-
The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors
-
Okomo-Adhiambo M, Hurt AC, Gubareva LV. The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors. Methods Mol Biol 2012; 865:95-113.
-
(2012)
Methods Mol Biol
, vol.865
, pp. 95-113
-
-
Okomo-Adhiambo, M.1
Hurt, A.C.2
Gubareva, L.V.3
-
18
-
-
0033961667
-
Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors
-
Tisdale M. Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors. Rev Med Virol 2000; 10:45-55.
-
(2000)
Rev Med Virol
, vol.10
, pp. 45-55
-
-
Tisdale, M.1
-
19
-
-
12244295453
-
Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network
-
Wetherall NT, Trivedi T, Zeller J et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 2003; 41:742-750.
-
(2003)
J Clin Microbiol
, vol.41
, pp. 742-750
-
-
Wetherall, N.T.1
Trivedi, T.2
Zeller, J.3
-
20
-
-
0037636478
-
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir
-
McKimm-Breschkin J, Trivedi T, Hampson A et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother 2003; 47:2264-2272.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 2264-2272
-
-
McKimm-Breschkin, J.1
Trivedi, T.2
Hampson, A.3
-
21
-
-
77956116079
-
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays
-
Nguyen HT, Sheu TG, Mishin VP et al. Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays. Antimicrob Agents Chemother 2010; 54:3671-3677.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 3671-3677
-
-
Nguyen, H.T.1
Sheu, T.G.2
Mishin, V.P.3
-
22
-
-
84867469314
-
Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva and June 2012
-
WHO
-
WHO. Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva and June 2012. Wkly Epidemiol Rec 2012; 87:369-374.
-
(2012)
Wkly Epidemiol Rec
, vol.87
, pp. 369-374
-
-
-
23
-
-
84882611877
-
Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
-
Okomo-Adhiambo M, Sleeman K, Lysen C et al. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. Influenza Other Respi Viruses 2013; 7:645-658.
-
(2013)
Influenza Other Respi Viruses
, vol.7
, pp. 645-658
-
-
Okomo-Adhiambo, M.1
Sleeman, K.2
Lysen, C.3
-
24
-
-
79952163859
-
Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective
-
Okomo-Adhiambo M, Sleeman K, Ballenger K et al. Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective. Viruses 2010; 2:2269-2289.
-
(2010)
Viruses
, vol.2
, pp. 2269-2289
-
-
Okomo-Adhiambo, M.1
Sleeman, K.2
Ballenger, K.3
-
25
-
-
67650410050
-
Influenza genome analysis using pyrosequencing method: current applications for a moving target
-
Deyde VM, Gubareva LV. Influenza genome analysis using pyrosequencing method: current applications for a moving target. Expert Rev Mol Diagn 2009; 9:493-509.
-
(2009)
Expert Rev Mol Diagn
, vol.9
, pp. 493-509
-
-
Deyde, V.M.1
Gubareva, L.V.2
-
26
-
-
50949106863
-
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
-
Sheu TG, Deyde VM, Okomo-Adhiambo M et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 2008; 52:3284-3292.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 3284-3292
-
-
Sheu, T.G.1
Deyde, V.M.2
Okomo-Adhiambo, M.3
-
27
-
-
84894452113
-
-
ISIRV-AVG. Available atAccessed 19 July 2013
-
ISIRV-AVG. Available at http://www.isirv.org/site/index.php/special-interest-groups/antiviral-group-home (Accessed 19 July 2013).
-
-
-
-
28
-
-
72049099839
-
Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007
-
Tashiro M, McKimm-Breschkin JL, Saito T et al. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007. Antivir Ther 2009; 14:751-761.
-
(2009)
Antivir Ther
, vol.14
, pp. 751-761
-
-
Tashiro, M.1
McKimm-Breschkin, J.L.2
Saito, T.3
-
29
-
-
1542509356
-
Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir
-
Hurt AC, Barr IG, Hartel G et al. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res 2004; 62:37-45.
-
(2004)
Antiviral Res
, vol.62
, pp. 37-45
-
-
Hurt, A.C.1
Barr, I.G.2
Hartel, G.3
-
30
-
-
33745635392
-
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
-
Monto AS, McKimm-Breschkin JL, Macken C et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006; 50:2395-2402.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 2395-2402
-
-
Monto, A.S.1
McKimm-Breschkin, J.L.2
Macken, C.3
-
31
-
-
84894414075
-
-
CDC. Available at:Accessed 19 July 2013
-
CDC. Available at: http://www.cdc.gov/flu/weekly/ (Accessed 19 July 2013).
-
-
-
-
32
-
-
84860334106
-
Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods
-
Nguyen HT, Fry AM, Gubareva LV. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods. Antivir Ther 2012; 17:159-173.
-
(2012)
Antivir Ther
, vol.17
, pp. 159-173
-
-
Nguyen, H.T.1
Fry, A.M.2
Gubareva, L.V.3
-
33
-
-
84894505423
-
-
WHO. Available at:Accessed 19 July 2013
-
WHO. Available at: http://www.who.int/influenza/gisrs_laboratory/flunet/en/ (Accessed 19 July 2013).
-
-
-
-
34
-
-
74849119655
-
Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses
-
Okomo-Adhiambo M, Nguyen HT, Sleeman K et al. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses. Antiviral Res 2010; 85:381-388.
-
(2010)
Antiviral Res
, vol.85
, pp. 381-388
-
-
Okomo-Adhiambo, M.1
Nguyen, H.T.2
Sleeman, K.3
-
35
-
-
84894422955
-
-
CDC. Available at:Accessed 19 July 2013
-
CDC. Available at: http://www.cdc.gov/flu/avianflu/h5n1-genetic-changes.htm (Accessed 19 July 2013).
-
-
-
|